Common Equity: The sum of all common equity items.
Harmony Biosciences Holdings, Inc. (HRMY) had Common Equity of $999.24M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$261.28M |
|
$75.43M |
|
$63.20M |
|
$198.08M |
|
$171.96M |
|
$89.32M |
|
$3.95M |
|
$93.27M |
|
$93.27M |
|
$75.43M |
|
$75.43M |
|
$75.43M |
|
$75.43M |
|
$89.32M |
|
$95.01M |
|
57.93M |
|
58.76M |
|
$1.30 |
|
$1.28 |
|
| Balance Sheet Financials | |
$814.33M |
|
-- |
|
$558.75M |
|
$1.37B |
|
$234.07M |
|
$133.96M |
|
$139.77M |
|
$373.84M |
|
|
Common Equity |
$999.24M |
$921.75M |
|
$999.24M |
|
58.12M |
|
| Cash Flow Statement Financials | |
$120.19M |
|
$-315.15M |
|
$-7.78M |
|
$752.77M |
|
$550.04M |
|
$-202.73M |
|
$19.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.48 |
|
-- |
|
-- |
|
0.12 |
|
0.15 |
|
75.81% |
|
34.18% |
|
34.18% |
|
-- |
|
35.70% |
|
28.87% |
|
$120.19M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
9.94 |
|
2.35 |
|
38.23 |
|
7.55% |
|
8.18% |
|
5.49% |
|
6.66% |
|
$17.19 |
|
$2.05 |
|
$2.05 |
|